Clinical effectiveness of platelets in additive solution treated with two commercial pathogen‐reduction technologies
Paolo Rebulla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Giuliano Grazzini, Federico Chiurazzi(University of Naples Federico II), Angelo Michele Carella(San Antonio College), G. Girelli(Sapienza University of Rome), Paola Isernia(Policlinico San Matteo Fondazione), Graf M(Federico II University Hospital), Giuseppe Marano, Barbara Olivero(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), N. Scarpato(Federico II University Hospital), Stefania Vaglio, Silvano Milani(University of Milan), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Maurizio Bonfichi(Policlinico San Matteo Fondazione), Rachele Montemezzi(University of Verona), Maurizio Marconi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Giorgio Gandini(University of Verona), Paolo Strada(Ospedale Policlinico San Martino), Francesco Beccaria(Ospedale Policlinico San Martino), Serelina Coluzzi(Policlinico Umberto I), L. Salvaneschi(Policlinico San Matteo Fondazione), Marianna Rinaldi(Agenzia Spaziale Italiana)
Cited by 75
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394